California Public Employees Retirement System Reduces Stock Position in The Ensign Group, Inc. $ENSG

California Public Employees Retirement System reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 7.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 134,667 shares of the company’s stock after selling 10,863 shares during the period. California Public Employees Retirement System’s holdings in The Ensign Group were worth $27,135,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in The Ensign Group by 9.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after buying an additional 230 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in The Ensign Group by 65.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after buying an additional 213 shares in the last quarter. Amundi increased its position in shares of The Ensign Group by 480,216.7% during the second quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after buying an additional 57,626 shares during the period. Finally, Brown Advisory Inc. increased its position in shares of The Ensign Group by 26.1% during the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after buying an additional 421 shares during the period. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

The Ensign Group Price Performance

Shares of NASDAQ ENSG opened at $170.87 on Wednesday. The firm has a market capitalization of $9.99 billion, a P/E ratio of 27.83, a P/E/G ratio of 1.68 and a beta of 0.69. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06. The stock’s 50-day simple moving average is $165.80 and its two-hundred day simple moving average is $184.01. The Ensign Group, Inc. has a twelve month low of $134.79 and a twelve month high of $218.00.

The Ensign Group (NASDAQ:ENSG) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The firm had revenue of $1.39 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same quarter last year, the company posted $1.52 EPS. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. As a group, equities analysts anticipate that The Ensign Group, Inc. will post 6.82 EPS for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Tuesday, June 30th. The Ensign Group’s dividend payout ratio (DPR) is currently 4.23%.

Analyst Upgrades and Downgrades

ENSG has been the subject of a number of analyst reports. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Royal Bank Of Canada reiterated an “outperform” rating on shares of The Ensign Group in a research note on Tuesday, June 9th. Truist Financial lowered their target price on shares of The Ensign Group from $215.00 to $202.00 and set a “hold” rating on the stock in a research note on Tuesday, July 14th. Finally, Weiss Ratings downgraded shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, June 16th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $213.50.

Insider Transactions at The Ensign Group

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of The Ensign Group stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total transaction of $114,996.00. Following the completion of the sale, the director directly owned 21,352 shares in the company, valued at $3,507,706.56. The trade was a 3.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.00% of the stock is currently owned by insiders.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.